EARLY ACCESS

// CGM DEVICES

Dexcom G7 vs FreeStyle Libre 3: Complete CGM Comparison 2024

Continuous glucose monitors (CGMs) have revolutionized diabetes management by providing real-time glucose readings without constant fingersticks. The Dexcom G7 and FreeStyle Libre 3 represent the latest flagship offerings from the two dominant CGM manufacturers, each bringing significant improvements over their predecessors. Both sensors are smaller, more accurate, and feature faster warm-up times than previous generations, making the choice between them more challenging than ever. While both devices provide excellent glucose monitoring capabilities, they differ meaningfully in accuracy metrics, cost structure, wear time, and integration features. The Dexcom G7 offers superior pump integration and predictive alerts, while the FreeStyle Libre 3 provides longer wear time and more frequent readings. Understanding these differences is crucial for diabetes management, as the right CGM can significantly impact time-in-range, A1C levels, and overall quality of life.

Winner
Dexcom G7

Dexcom G7

$300

FreeStyle Libre 3

FreeStyle Libre 3

$150

[FEATURE COMPARISON]

Feature Dexcom G7 FreeStyle Libre 3

Accuracy (MARD)

Mean Absolute Relative Difference - lower numbers indicate better accuracy against lab reference values

8.2% (adults), 8.1% (pediatrics) 7.9-8.9% (study dependent), 9.4% (pediatrics)

Reading Frequency

How often the sensor transmits glucose data to your phone or receiver

Every 5 minutes Every 1 minute

Sensor Wear Time

How long you can wear the sensor before replacement, including any grace periods

10.5 days (10 days + 12-hour grace period) 14 days

Warm-up Time

Time from sensor application until you receive your first glucose reading

30 minutes (automatic start) 60 minutes (requires phone scan to start)

Monthly Cost

Typical out-of-pocket monthly cost for most insured patients in the US

$0-100 (most pay $0) $80+ (often $150+ uninsured)

Sensor Size & Profile

Physical dimensions and how discreet the sensor appears when worn

24×27.3×4.6mm, circular design, 60% smaller than G6 21mm diameter×2.9mm height, smallest available CGM

Pump Integration

Compatibility with automated insulin delivery (AID) systems and smart insulin devices

Omnipod 5, Tandem t:slim X2, iLet, Tandem Mobi, Lilly Tempo Pen iLet Bionic Pancreas, twiist AID (limited options)

Predictive Alerts

Advanced warning systems that predict glucose trends before they become dangerous

Urgent Low Soon (20-minute advance warning), customizable trend alerts Standard high/low alarms only (no predictive alerts)

[PROS & CONS]

Dexcom G7

Pros

  • Fastest 30-minute warm-up time with automatic start
  • Urgent Low Soon predictive alerts prevent dangerous lows
  • Extensive pump integration (Omnipod 5, Tandem, iLet)
  • Most insured patients pay $0 out-of-pocket
  • 12-hour grace period for convenient sensor changes

Cons

  • Shorter 10.5-day wear time requires more frequent changes
  • Less frequent readings (every 5 minutes vs every minute)
  • Slightly larger sensor profile than Libre 3

FreeStyle Libre 3

Pros

  • Longest 14-day wear time reduces insertion frequency
  • Smallest, thinnest sensor design available
  • Most frequent readings (every minute)
  • Slightly better accuracy in some independent studies
  • No overpatch required for secure adhesion

Cons

  • Higher out-of-pocket costs ($80+ monthly for most)
  • Limited pump integration options
  • No predictive low glucose alerts
  • 60-minute warm-up requires manual phone scan to start

[OUR VERDICT]

Dexcom G7 wins due to superior safety features, extensive pump integration, better insurance coverage, and predictive alerts that the Libre 3 lacks.

The choice between Dexcom G7 and FreeStyle Libre 3 ultimately depends on your specific diabetes management needs and priorities. For most users seeking the most comprehensive CGM experience, the Dexcom G7 emerges as the stronger choice due to its superior ecosystem integration, predictive safety features, and better insurance coverage. The G7's Urgent Low Soon alert, which provides 20-minute advance warning of dangerous lows, is a game-changing safety feature that the Libre 3 cannot match. Additionally, its extensive pump compatibility makes it essential for users of automated insulin delivery systems.

From an accuracy standpoint, both sensors perform exceptionally well, with study results showing conflicting data depending on methodology. Independent head-to-head studies suggest the Libre 3 may have a slight accuracy edge (7.9% vs 8.2% MARD), while Dexcom-sponsored studies show the opposite. In practice, both sensors meet FDA accuracy standards and provide clinically acceptable performance for insulin dosing decisions.

The FreeStyle Libre 3 excels in specific areas that may appeal to certain users. Its 14-day wear time reduces insertion frequency, and the every-minute readings provide more granular glucose data. The smaller sensor profile makes it the most discreet option available. However, its limited pump integration, lack of predictive alerts, and typically higher out-of-pocket costs significantly limit its appeal for comprehensive diabetes management.

For budget-conscious users, the cost difference is substantial. Most insured patients pay $0 for Dexcom G7, while Libre 3 often costs $80+ monthly. This pricing advantage, combined with superior features, makes the G7 the better value proposition for most people with diabetes.

Our pick:

Dexcom G7

Track Dexcom G7 and FreeStyle Libre 3 in BodyOS

Connect your devices to see unified insights in one place.

[RELATED COMPARISONS]